CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating

Negative
AI Analysis

Summary

UBS reduced its price target for IDEXX Laboratories from $640 to $620 while maintaining a Neutral rating on the stock.

Importance:2/10
Sentiment:
-0.30
price_target_reductionanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 27, 2026 1:57 PM

Read Original